MetaADEDB 2.0 @ LMMD
intensive care
(UMLS:C0085559)
Definition:
Advanced and highly specialized care provided to medical or surgical patients whose conditions are life-threatening and require comprehensive care and constant monitoring. It is usually administered in specially equipped units of a health care facility.
UMLS ID:
C0085559
MeSH ID:
D003422
Classification 1:
Name:
Therapeutics
MeSH Tree Number(s):
E02.760.190
Classification 2:
Name:
Health Care Facilities, Manpower, and Services
MeSH Tree Number(s):
N02.421.585.190
Synonym(s)
1.
intensive care
2.
Intensive Care
3.
Intensive care
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1BaclofenFAERS: 11
Canada Vigilance: 1		Canada Vigilance
US FAERS
2CinacalcetFAERS: 8US FAERS
3riociguatFAERS: 6
Canada Vigilance: 1		Canada Vigilance
US FAERS
4ClozapineFAERS: 5
Canada Vigilance: 6		Canada Vigilance
US FAERS
5Insulin GlargineFAERS: 5US FAERS
6CiprofloxacinFAERS: 4US FAERS
7ColchicineFAERS: 4US FAERS
8RivaroxabanFAERS: 4US FAERS
9ambrisentanFAERS: 4US FAERS
10venetoclaxFAERS: 4US FAERS
114-hydroxybutyric acidFAERS: 3US FAERS
12Abiraterone AcetateFAERS: 3US FAERS
13Anoro ElliptaFAERS: 3US FAERS
14MoxifloxacinFAERS: 3US FAERS
15RifaximinFAERS: 3US FAERS
16SorafenibFAERS: 3US FAERS
174-AminopyridineFAERS: 2US FAERS
18CyclosporineFAERS: 2US FAERS
19LapatinibFAERS: 2US FAERS
20Mycophenolic AcidFAERS: 2US FAERS
21OmeprazoleFAERS: 2US FAERS
22Paliperidone PalmitateFAERS: 2US FAERS
23Raltegravir PotassiumFAERS: 2US FAERS
24RitonavirFAERS: 2US FAERS
25TacrolimusFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
26TolvaptanFAERS: 2US FAERS
27carbidopa, levodopa drug combinationFAERS: 2US FAERS
28lumacaftor, ivacaftor drug combinationFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
29patiromerFAERS: 2US FAERS
30pazopanibFAERS: 2US FAERS
31ziprasidoneFAERS: 2US FAERS
324-[(1R)-2-[6-[2-[(2,6-Dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate;diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanolFAERS: 1US FAERS
33AlbuterolFAERS: 1US FAERS
34AlbuterolFAERS: 1US FAERS
35Aspirin-oxycodone hydrochloride-oxycodone terephthalate combinationFAERS: 1US FAERS
36Breo ElliptaFAERS: 1US FAERS
37BupivacaineFAERS: 1US FAERS
38CarvedilolFAERS: 1US FAERS
39DarunavirFAERS: 1US FAERS
40DiclofenacFAERS: 1US FAERS
41DronedaroneFAERS: 1US FAERS
42FentanylFAERS: 1US FAERS
43FluticasoneFAERS: 1US FAERS
44FondaparinuxFAERS: 1US FAERS
45Fosamax plus DFAERS: 1US FAERS
46Ibandronic AcidFAERS: 1US FAERS
47IloprostFAERS: 1US FAERS
48Janumet XRFAERS: 1US FAERS
49LacosamideFAERS: 1US FAERS
50LamotrigineFAERS: 1US FAERS
51MDV 3100FAERS: 1US FAERS
52NorgestrelFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
53OrlistatFAERS: 1US FAERS
54Quetiapine FumarateFAERS: 1US FAERS
55RilpivirineFAERS: 1US FAERS
56RocuroniumFAERS: 1US FAERS
57RosiglitazoneFAERS: 1US FAERS
58ScopolamineFAERS: 1US FAERS
59TeriparatideFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
60TrisequensFAERS: 1US FAERS
61brexpiprazoleFAERS: 1US FAERS
62eltrombopagFAERS: 1US FAERS
63empagliflozinFAERS: 1US FAERS
64ezogabineFAERS: 1US FAERS
65iopromideFAERS: 1US FAERS
66liposomal amphotericin BFAERS: 1US FAERS
67niraparibFAERS: 1US FAERS
68regorafenibFAERS: 1US FAERS
69sofosbuvir-velpatasvir drug combinationFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
70AzathioprineOFFSIDES
71DutasterideOFFSIDES
72NicorandilOFFSIDES
73TemozolomideCanada Vigilance: 1Canada Vigilance
74iodixanolCanada Vigilance: 1Canada Vigilance
75loxoprofenOFFSIDES
76semaglutideCanada Vigilance: 1Canada Vigilance
Similar ADE(s)
NameSemantic Similarity
1Palliative Care44.8%
2Preoperative Care36.1%
3Hospice Care32.8%
4Postoperative Care26.5%
5Euthanasia26%
6Emergency Care20.9%
7Neurological Rehabilitation18.8%
8Medication Error17.2%
9Mechanical ventilation15.3%
10Bed rest14.6%
11Inhalation Therapy14.6%
12Phototherapy14.6%
13Respiratory Therapy14.6%
14Salvage Therapy14.6%
15Renal Replacement Therapy14.6%
16Apitherapy14.6%
17Chemotherapy14.6%
18Cryotherapy14.6%
19Inappropriate Prescribing14.5%
20Plasmapheresis14%
21Enteral Nutrition12.1%
22Parenteral Nutrition12.1%
23Manual Lymphatic Drainage11.8%
24Intubation11.3%
25Lithotripsy10.9%
26Laser Therapy10.9%
27Pain management10.7%
28Patient Isolation10.6%
29Peritoneal Dialysis10.2%
30Antibiotic Prophylaxis10.2%
31Massage9.6%
32Brachytherapy9.3%
33Chelation Therapy9.3%
34Diathermy9.3%
35Premedication9.3%
36Sclerotherapy9.3%
37Tocolysis9.3%
38Male Contraception9.3%
39Pleurodesis9.3%
40Phytotherapy9.3%
41Nutritional Support9.3%
42Hormone replacement therapy9.3%
43Transcranial magnetic stimulation9.3%
44Leukapheresis8.6%
45Continuous Positive Airway Pressure8.3%
46Deep Brain Stimulation7.3%
47Extracorporeal Membrane Oxygenation7%
48Radiofrequency Ablation7%
49Cementoplasty7%
50Paracentesis6.9%
51Dermabrasion6.9%
52Electrocoagulation6.9%
53Face Lift6.9%
54Plasma Exchange6.8%
55Injection6.8%
56Platelet Transfusion5.6%
57rhinoplasty5.6%
58Ovulation Induction5.1%
59Relaxation Therapy5.1%
60Vertebroplasty5.1%
61Barium Enema5%
62Angioplasty4.6%
63Bottle feeding4.5%
64venipuncture4.5%
65Drug Overdose4.3%
66Photopheresis4.3%
67Immunosuppression4.3%
68Ketogenic Diet4.1%
69Immunoglobulin Therapy3.8%
70Gastroplasty3.4%
71Keratoplasty3.4%
72Atherectomy3.3%
73Superovulation3.3%
74Gastric Bypass2.8%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.